UPDATE 2-Novartis gets approval to sell Kymriah in Japan for $306,000 By: Reuters: Company News May 15, 2019 at 04:24 AM EDT * Novartis still tackling U.S. drug specification issues (Adds comment from Novartis, background) Read More >> Related Stocks: Gilead Sciences Novan Inc